EVALUATION OF COMPLIANCE WITH TUBERCULOSIS PATIENTS IN CONSUMING ANTI-TUBERCULOSIS MEDICINE (OAT) IN OUTPATIENT PATIENTS AT THE HEALTH CENTER WHEN

Tia Fitria Tamrin; Ahmad Husain  Palli; Atvinda Pirlya Afista

doi:10.47918/jhts.v4i4.436

Tia Fitria Tamrin Universitas Bina Mandiri
Ahmad Husain Palli Universitas Bina Mandiri Gorontalo
Atvinda Pirlya Afista Universitas Bina Mandiri Gorontalo

DOI: https://doi.org/10.47918/jhts.v4i4.436

Keywords: Compliance, Tuberculosis, Consuming OATS

Abstract

This study aims to find out the patient's compliance level, the characteristics of pulmonary TB patients, and to find out the factors that affect compliance in outpatients at Kabila Health Center. The study was conducted using a quantitative approach, the population in this study is all outpatient tuberculosis patients at Kabila Health Center involving 28 sampling techniques used in this study are total sampling. This study is a descriptive study conducted observationally using research instruments, namely, The Informed Consent Form and the MMAS-8 Questionnaire.

Data analysis is done using descriptive data analysis. From the results of the search of patient characteristics consisting of gender, age, education, and work, patients in Kabila health centers have a high level of adherence in the use of drugs for the healing process of TB disease. It can be seen in the results of the above study where the patient's compliance rate obtained a high category of 23 people or 82.14% low 5 or 17.85%.

Keywords: Compliance, Tuberculosis, Consuming OATS.

References

[1] Arditia, 2018. The Correlation of Characteristics, Knowledge, Attitudes and Actions of Pulmonary Tuberculosis Patients with Drug Compliance at Taah Kalikewall Health Center. [Thesis thesis]. Airlangga University.
[2] Ana, S. 2012. Evaluation of Drug Use Compliance in Outpatient Tuberculosis Patients at the Surakarta Community Pulmonary Health Center 2012. Thesis. Faculty of Pharmacy. Muhammadiyah Surakarta university.
[3] Armelia, 2011 Evaluation of Compliance with Medication for Patients with Pulmonary Tuberculosis in 2010-2011 at the Pancoran Mas District Health Center, Depok, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Indonesia.
[4] Arsin, A., & Azriful. 2004. Several Factors Related to the Incidence of Pulmonary Tuberculosis in the Working Area of Kassi Makassar Public Health Center. Journal of Medika Nusantara, 25 (3). Makassar. Pages: 39-40.
[5] Asrul et al, Evaluation of the Use of Antituberculosis Drugs (OAT) in Pulmonary Tuberculosis Patients at Jumpandang Baru Health Center Makassar, Department of Pharmacy FKIF Alauddin State Islamic University Makassar.
[6] Aditama, TY 2002. Tuberculosis Diagnosis, Treatment and Problems. 5th Edition. Indonesian Doctors Association Publishing Foundation, Jakarta.
[7] Centers for Disease Control and Prevention (CDC). 2013 Latent Tuberculosis Infection: A Guide for

Primary Health Care Providers. Available:
[8] Darmanto, D., 2014. Respirology. Issue 2.: EGC Medical Book Publisher. Jakarta
[9] Danusantoso, H., 2012. Pocket Book of Lung Disease. Jakarta: Hippocrates
[10] Indonesian Ministry of Health, 2018. Tuberculosis.: Data and Information Center of the Indonesian Ministry of Health. Jakarta.
[11] Ministry of Health of the Republic of Indonesia, 2014, National Guidelines for Tuberculosis Control, Edition 2, 30-31, MOH, 2014, Jakarta.
[12] South Sulawesi Provincial Health Office. 2014. Health Profile of South Sulawesi. Makassar Dipiro, JT, Wells, BG, Schwinghammer, TL,
[13] Ministry of Health of the Republic of Indonesia 2011. National Guidelines for the Prevention of Tuberculosis. Directorate General of Disease Control and Environmental Health. Jakarta.
[14] Ministry of Health of the Republic of Indonesia. 2009. Indonesian Health Profile. Indonesian Ministry of Health, Jakarta.
[15] Bantul District Health Department. 2016. Health ProfileBantul Regency, Yogyakarta Special Region.
[16] Indonesian Ministry of Health. 2008. National Guidelines for Tuberculosis Management, : Gedurnas TB. Issue 2 p. 4-6. Jakarta
[17] Indonesian Ministry of Health. 2007. Pharmaceutical Care for Tuberculosis.
Jakarta:
[18] Ministry of Health of the Republic of Indonesia. Pages: 6, 14-28,
30.
[19] Indonesian Ministry of Health. 2002, National Guidelines for Combating Tuberculosis, 8th Print. Jakarta.
[20] Bone Bolango Health Service 2020, TB Prevalence Data in Each District.
[21] Dipiro, CV Pharmacotherapy Handbook, Seventh Edition,.2009.532-533, McGraw-Hill Medical, New York.
[22] Hastono. SP. 2017, Health statistics. Jakarta: Rajawali Press.